This is the authors' abstract. We don't add key points for this paper.
Innovative microfluidic technology aims to create more realistic in vitro simulations of human tissues. Organ-on-a-chip (OoC) devices within microfluidic chips mimic in vivo environments but face limitations due to inert material between compartments, hindering cell interaction. Current membranes made of PDMS or plastic impede proper cell-nutrient exchange and induce unexpected cell responses. This work focuses on minimizing inert materials while maximizing cell-matrix and cell-cell interactions in microfluidic chips.
No takes yet. Share an insight, caveat, or question.
Rodrigo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: